Literature DB >> 25075020

Anti-tumor effect of novel cationic biomaterials in prostate cancer.

Gunjan Gakhar1, Huixian Liu2, Roquian Shen1, Douglas Scherr2, Dequn Wu3, David Nanus1, Chih-Chang Chu4.   

Abstract

BACKGROUND: Tumor cells expressing excessive anionic-charged sialic acid can be potentially targeted by cationic polymers which may inhibit tumor growth. In the present study, three new families of cationic polymers were synthesized to assess their effects on prostate cancer cells.
MATERIALS AND METHODS: Cationic polymers effects on PC3 prostate cancer cells and normal prostate epithelial cell (RWPE-1) were assessed using cell viability, DNA fragmentation, apoptosis assays and confocal microscopy.
RESULTS: The dextran-based polymer (Dex-PA-3X) (40 μg/ml) and the vinyl-based PolyAETA (5 μg/ml) induced a significant reduction in cell viability in PC3 cells (85% and 50%, respectively; p<0.05) in comparison to RWPE-1 cells. Furthermore, Dex-PA-3X induced a 50%, and PolyAETA induced a 35% increase in cell death in PC3 cells compared to RWPE-1 cells measured by DNA fragmentation assay. Lower concentrations of both polymers induced apoptosis while higher concentrations induced both apoptosis and necrosis by immunostaining. Confocal microscopy indicated the localization of Dex-PA in the cytoplasm of PC3 but not RWPE-1 cells, while PolyAETA was seen in both PC3 and RWPE-1 cells, but at lower intensity in RWPE-1 cells.
CONCLUSION: The newly-synthesized cationic polymers Dex-PA-3X and PolyAETA selectively bind to, reduce viability and induce cell apoptosis in prostate cancer cells, suggesting that targeting negatively-charged tumor cells could be a novel strategy to treat prostate cancer. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Amino acid-based poly (ester-amide)s; apoptosis; arginine; cationic polymers; chitosan; cytotoxicity; dextran; lysine; necrosis; polysaccharides; prostate cancer

Mesh:

Substances:

Year:  2014        PMID: 25075020

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Polyvinyl Alcohol Carbazate as a Polymer-Based Antitumoral Agent.

Authors:  Felix Sellberg; Robin Fröbom; Christian Binder; Erik Berglund; David Berglund
Journal:  Front Oncol       Date:  2021-01-11       Impact factor: 6.244

2.  Targeted Chinese Medicine Delivery by A New Family of Biodegradable Pseudo-Protein Nanoparticles for Treating Triple-Negative Breast Cancer: In Vitro and In Vivo Study.

Authors:  Hiu Yee Kwan; Qinghua Xu; Ruihong Gong; Zhaoxiang Bian; Chih-Chang Chu
Journal:  Front Oncol       Date:  2021-01-20       Impact factor: 6.244

3.  Anticancer polymers designed for killing dormant prostate cancer cells.

Authors:  Haruko Takahashi; Kenji Yumoto; Kazuma Yasuhara; Enrico T Nadres; Yutaka Kikuchi; Laura Buttitta; Russell S Taichman; Kenichi Kuroda
Journal:  Sci Rep       Date:  2019-01-31       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.